SERPING1 and angioedema: Whether these modified serpins will make it to the clinic remains to be seen, but recombinant C1INH produced in the milk of transgenic rabbits is approved for the treatment of hereditary angioedema in some jurisdictions (Ruconest®, Salix Pharmaceuticals).